Three Are Thwarted In Latest Lacosamide Gambit In US

 
• By Aidan Fry
  
ChessBoard
US generics players' latest gambit to invalidate a key patent protecting Vimpat has failed • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin